TERF2 and neoplasm: By contrast, both drugs induced a significant decrease in the tumor volume of TRF2-overexpressing xenografted tumors, leading to significantly smaller tumor sizes at day 26 (Figure 2E, middle panels; p < 0.0001) but also of the tumor growth rate (Figure 2F–H) at each time-point.